Altamira Therapeutics Ltd. Gains 55.14%
Mon, Apr 11, 2022 at 05:30 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) jumped higher at $1.66, a gain of 55.1%. The stock appeared on our News Catalysts scanner on Mon, Apr 11, 2022 at 10:14 AM in the 'MISCELLANEOUS' category. From Mon, Mar 28, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
The stock spiked on Fri, Nov 12, 2021 at $3.33 with a volume of 194M+, and its share price has been moving sideways in recent weeks.
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Veru Inc. (VERU:NASDAQ), 182.3%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 71.57%
- Athersys, Inc. (ATHX:NASDAQ), 63%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 55.14%
- Genocea Biosciences, Inc. (GNCA:NASDAQ), 50%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 35.41%
- 21Vianet Group, Inc. (VNET:NASDAQ), 29.63%
- SailPoint Technologies Holdings, Inc. (SAIL:NYSE), 29.16%
- Reading International, Inc. (RDIB:NASDAQ), 25.54%
- 5E Advanced Materials Inc. (FEAM:NASDAQ), 24%